Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ConfiDisc introduces US patented anti-illegal drug syringe
ConfiDisc said that the disc restricts the view of the user and disallows the proper injection angle needed for intravenous injection and is virtually impossible to inject at
ConfiDisc said that the disc restricts the view of the user and disallows the proper injection angle needed for intravenous injection and is virtually impossible to inject at
GSK said that unfortunately, birth defects occur in three to five percent of all live births, whether or not the mother was taking medication during pregnancy. GSK believes
The Phase III programme is being performed in conjunction with GW Pharma’s licensing partner for Sativex in the US, Otsuka Pharmaceutical. The programme, which is fully funded by
Epanova is an Omega 3 fatty acid containing a new formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Omthera Pharma said that the multi-center, placebo-controlled, randomised, double-blind,
Generally, all Canadian drug establishments must hold an EL to manufacture, package, or conduct testing of pharmaceutical products. A5 Labs president and CEO Richard Azani said that in
Winston’s trial showed that, in the 210 patient Phase II double-blind, vehicle-controlled, multi-center study on patients with more than 180 headache days per year, twice-daily administration of Dolorac
MIM-D3 is a small cyclic peptidomimetic of NGF, a naturally occurring protein in the eye that is responsible for the maintenance of corneal nerves and epithelium, mucin and
Basilea Pharma claims that BAL30072 has broad antimicrobial activity against multidrug-resistant Gram-negative ‘superbugs’ that are increasingly associated with potentially life- threatening infections in hospitals around the world. Additionally,
Evotec will provide drug discovery expertise covering in-vitro biology, medicinal chemistry and in-vitro and in-vivo pharmacology. As part of the collaboration, Evotec will apply their integrated drug discovery
Profil Institute for Clinical Research Cardiometabolic Research director Robert Schott said that assessing cardiac safety is a critical early objective for the evaluation of new drugs, particularly in